Artelo Biosciences ARTL
$ 1.15
-0.86%
Quarterly report 2024-Q3
added 11-12-2024
Artelo Biosciences Financial Statements 2011-2024 | ARTL
Annual Financial Statements Artelo Biosciences
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
4.82 M | 6.11 M | 1.12 M | 3.44 M | 4.69 M | 1.9 M | - | - | - | - | - | - | - |
Shares |
3.19 M | 2.86 M | 2.82 M | 3.47 M | 2.17 M | 1.28 M | - | - | - | - | - | - | - |
Historical Prices |
1.51 | 2.14 | 0.397 | 1.84 | 1.07 | - | - | - | - | - | - | - | - |
Net Income |
-9.29 M | -10.1 M | -4.04 M | -4.65 M | -2.17 M | -2.34 M | -235 K | -29.7 K | -15.2 K | -15.3 K | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-9.93 M | -10.3 M | -4.04 M | -4.69 M | -3.21 M | -2.34 M | -233 K | -29.7 K | -15.2 K | -15.3 K | - | - | - |
Interest Expense |
- | 5 K | - | - | - | - | 2.1 K | - | - | - | - | - | - |
EBITDA |
-9.93 M | -10.3 M | -4.04 M | -4.69 M | -3.21 M | -2.34 M | -233 K | -29.7 K | -15.2 K | -15.3 K | - | - | - |
Operating Expenses |
9.93 M | 10.3 M | 4.04 M | 4.69 M | 3.21 M | 2.34 M | 233 K | 29.7 K | 15.2 K | - | - | - | - |
General and Administrative Expenses |
4.23 M | 5.96 M | 2.1 M | 1.79 M | 2.12 M | 1.09 M | 233 K | 29.7 K | 15.2 K | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Artelo Biosciences
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
3.23 M | 3.23 M | 3.23 M | 3.19 M | 3.16 M | 2.86 M | 2.86 M | 2.86 M | 2.86 M | 42.6 M | 42.3 M | 2.82 M | 24.5 M | 23.1 M | 30.4 B | 11.5 M | 3.42 M | 3.47 M | 3.43 M | 3.36 M | 1.9 M | 2.06 M | 1.92 M | 1.75 M | 1.49 M | 1.59 M | 11.7 M | 11.3 M | 8.03 M | 8.81 M | 11.3 M | 7.64 M | 7.64 M | 7.64 M | 7.64 M | 7.64 M | 6.11 M | 6.31 M | 7.64 M | 6 M | 2.09 M | 6 M | 99.4 K | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-1.13 M | -2.43 M | -2.48 M | - | -2.45 M | -1.6 M | -2.17 M | - | -2.33 M | -2.45 M | -1.96 M | -4.04 M | -2.24 M | -2.25 M | -1.7 M | -2.06 M | -1.43 M | -1.43 M | -1.43 M | -1.31 M | -1.31 M | -1.31 M | -1.31 M | -557 K | -557 K | -557 K | -557 K | -277 K | -119 K | -96.6 K | -277 K | -9.52 K | - | -5.05 K | -9.52 K | -15.2 K | -10.6 K | -2.5 K | -15.2 K | -2 K | -14.7 K | -15.3 K | -6.6 K | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-1.2 M | -2.51 M | -2.59 M | - | -2.61 M | -1.78 M | -2.29 M | - | -2.39 M | -2.47 M | -1.95 M | -2.55 M | -2.24 M | -2.25 M | -1.7 M | -1.44 M | -3.66 M | -951 K | -1.44 M | -1.34 M | -2.26 M | -941 K | -1.34 M | -557 K | -1.65 M | -578 K | -557 K | -277 K | -117 K | -95.7 K | -277 K | -9.52 K | - | -5.05 K | -9.52 K | -15.2 K | -10.6 K | -2.5 K | -15.2 K | -2 K | -14.7 K | -8.15 K | -6.6 K | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | 5 K | - | - | - | - | 1.62 K | 1.59 K | 567 | 30.7 K | 204 | 408 | 30.1 K | 930 K | 596 K | 30.1 K | - | - | - | - | - | 1.92 K | 907 | 1.02 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | - | - | -2.39 M | -2.47 M | -1.95 M | -2.55 M | -2.24 M | -2.25 M | -1.7 M | -1.44 M | -3.66 M | -951 K | -1.44 M | -1.34 M | -2.26 M | -941 K | -1.34 M | -557 K | -1.65 M | -578 K | -557 K | -277 K | -117 K | -95.7 K | -277 K | -9.52 K | - | -5.05 K | -9.52 K | -15.2 K | -10.6 K | -2.5 K | -15.2 K | -2 K | -14.7 K | -8.15 K | -6.6 K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
1.2 M | 2.51 M | 2.59 M | - | 2.61 M | 1.78 M | 2.29 M | - | 2.39 M | 2.47 M | 1.95 M | 4.04 M | 2.24 M | 2.25 M | 2.55 M | 2.07 M | 3.66 M | 951 K | 1.44 M | 1.34 M | 2.26 M | 941 K | 1.34 M | 557 K | 1.65 M | 578 K | 557 K | 277 K | 117 K | 95.7 K | 277 K | 9.52 K | - | 5.05 K | 9.52 K | 15.2 K | 10.6 K | 2.5 K | 15.2 K | 2 K | 14.7 K | 8.15 K | 6.6 K | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
870 K | 827 K | 1.08 M | - | 1.03 M | 1.03 M | 1.06 M | - | 1.32 M | 1.42 M | 1.48 M | 2.1 M | 1.21 M | 1.28 M | 1.28 M | 1.07 M | 1.23 M | 389 K | 396 K | 403 K | 666 K | 403 K | 403 K | 206 K | 272 K | 105 K | 206 K | 137 K | 23.4 K | 19.3 K | 137 K | 313 | - | 609 | 313 | 609 | - | - | 609 | - | 3.74 K | 3.65 K | 95 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency